Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Ad image

FDA approval in the United States: Sciencealert

MONews
3 Min Read

The two US biotechnology companies said that food pharmacies have liquidated to conduct clinical trials of genetic editing pigs for human transplantation.

Along with United Therapeutics, another company, Egenesis, has been working in an experiment to transplanting pigs to humans since 2021. Early brain-guard patients and recent live prisoners.


Advocates hope that this approach will help to solve serious long -term shortages. More than 100,000 people in the United States are waiting for transplantation, including more than 90,000 people who need height.

In 2024, almost 90,000 people in the United States were waiting for the kidney transplant. (Organdonor.gov))

The approval of the United Therapeutics announced on Monday allowed the company to develop technology into license products when the trial was successful.


Research approval Welcome to A Leigh Peterson, vice president of the company, “We have begun to achieve important development in our constant mission to expand the availability of transplantable organs.


The test will initially expand to 50 people before registering six patients with terminal kidney disease, United Therapy Artis said in a statement. The first transplant is expected in mid -2012.


Meanwhile, rival Egenesis announced that it was approved for FDA for a separate three -person renal research in December.


“This study is listed for transplantation but will assess patients with kidney failures who are less likely to receive a donor proposal for five years,” the company said.


Organ transplantation from one species to another was an enthusiastic but ambiguous goal of science.


The initial experiments of primates were shaken, but due to the development of genetic editing and immune management, the field was more closer to reality.


Pig has emerged as an ideal donor. They grow quickly, produce large garbage, and are already part of human food.


United Therapeutics said that test patients will monitor life by evaluating the risk of animal infections, which are survival, kidney function, and animal to humans.


Currently, Towana Looney, a 53 -year -old from Alabama, who received the United Therapeutics Kidney on November 25, 2024, has only one living human recipient of a pig institution.


She is also the longest vertical winner of lives with pig height for 71 days on Tuesday. Maryland’s David Bennett received a pig heart in 2022 and survived for 60 days.

© Agace France-Presse

Share This Article